Gaetano Bertino

University of Catania

Papers

1

Total Citations

180

H-Index

1

About

Dr. Gaetano Bertino is a leading hepatologist whose work has fundamentally shaped the clinical management of benign liver tumors, particularly hepatic hemangiomas. His landmark 2014 review, "What is changing in indications and treatment of hepatic hemangiomas," has garnered over 180 citations, serving as a definitive guide for clinicians navigating the diagnostic and therapeutic challenges of these common lesions. By synthesizing evidence on the natural history of hepatic cavernous hemangiomas—which account for 73% of benign liver tumors—Bertino clarified when intervention is truly necessary, shifting practice away from unnecessary surgery toward conservative management. His research has been instrumental in establishing evidence-based criteria for treatment, emphasizing that most patients with incidentally discovered hemangiomas require only observation. Beyond this seminal work, Bertino has contributed broadly to hepatology, advancing understanding of liver disease diagnosis and management. His scholarship bridges the gap between radiological findings and clinical decision-making, making him an essential reference for gastroenterologists, hepatologists, and surgeons. For students and researchers, Bertino exemplifies how focused, high-impact reviews can transform clinical practice by providing clarity on complex, frequently encountered conditions.

Research Focus

Key Achievements

1
H-Index
1
Papers
180
Total Citations
180
Avg Citations/Paper
🏆 Most Cited Paper
What is changing in indications and treatment of hepatic hemangiomas. A review
180 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University of Catania

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago